Zevay GLP-1 Review 2026: Could This Lower-Cost Telehealth Option Be the Right Fit for Your Weight-Management Goals?

As more adults compare convenient and potentially more affordable GLP-1 care in 2026, this Zevay review explores advertised semaglutide and tirzepatide pricing, online provider evaluation, pharmacy fulfillment, eligibility requirements, and the practical details buyers should understand before enrolling.

Quick disclosure before you dive in: this is a paid advertorial, and a commission is earned if you purchase through links in this article. Product and program claims come from Zevay, LLC and aren't independently endorsed here. Zevay is a technology platform, not a medical practice or pharmacy - prescription medication is available only after an independent, licensed provider reviews and approves you, and approval isn't guaranteed. The compounded medications discussed below aren't FDA-approved and haven't been FDA-reviewed for safety, effectiveness, or quality before marketing. This content is promotional and meant to help you evaluate a real telehealth program, not to replace medical advice. Official site: zevay.com. Details reflect materials reviewed in July 2026 - confirm anything time-sensitive before you enroll.

Zevay GLP-1 Program Overview 2026: Pricing, Eligibility, Compounded Semaglutide vs Tirzepatide Explained

You saw an ad for Zevay - maybe a video, maybe a feed post about compounded semaglutide or tirzepatide at a price that actually looked reasonable. It caught your attention, and now you want the real story: what you'd actually pay, who actually prescribes it, and whether the whole thing holds up before you hand over your information. That's exactly what a smart buyer does, and it's exactly what this rundown covers - pricing, eligibility, the people actually involved, and the handful of things worth double-checking before you sign up.

Zevay GLP-1 Quick Snapshot

  • What it is: telehealth platform advertising access to compounded semaglutide and tirzepatide, per Zevay's own site

  • Who reviews you: an independent licensed physician network Zevay identifies as Telegra MD

  • Who prescribes: not Zevay - a licensed provider makes an independent clinical decision

  • Cost: compounded Semaglutide from $149/month, compounded Tirzepatide from $187/month, per Zevay's dedicated product pages - a third figure ($199/month, unspecified medication) appears on the general landing page (see below)

  • FDA status: compounded preparations discussed here are not FDA-approved

  • Cancellation: online account or help@zevay.com, 3 business days before renewal

  • Non-approval refund: full refund, per Zevay's FAQ

See current Zevay GLP-1 program pricing and eligibility

What Is Zevay and Who Is It For?

Zevay, LLC describes itself as a patient management platform, not a medical practice, prescriber, or pharmacy in its own right. According to the brand, Zevay partners with independent licensed physician networks, including a group identified on Zevay's site as Telegra MD, to connect users with providers who make their own clinical decisions about whether compounded GLP-1 medication is appropriate. Prescriptions, when issued, are filled through pharmacy partners the brand names as Southend Pharmacy in Houston, Texas, and Boothwyn Pharmacy in Kennett Square, Pennsylvania.

Three separate entities, three separate jobs, and none of them is a stand-in for the others:

  • Zevay - runs the online intake and account experience

  • The medical group (Telegra MD, per Zevay's site) - reviews your information and makes the prescribing decision

  • The pharmacy (Southend or Boothwyn) - compounds and ships the medication if a provider decides it's appropriate for you

The brand's own terms are explicit that Zevay itself doesn't practice medicine or pharmacy.

Adults researching Zevay are generally comparing its online intake, independent provider review, compounded-medication pathway, advertised pricing, and recurring subscription terms with other care options available to them. The service isn't designed for emergency or urgent care - Zevay's own terms say plainly that it's not intended for emergency or urgent situations - and completing the intake doesn't guarantee that a provider will prescribe medication.

Buyer Takeaway: Zevay is a platform, not the prescriber or the pharmacy - the actual prescribing decision sits with an independent licensed provider, and the actual medication is compounded by a separate licensed pharmacy.

Buyer Takeaway: A prescription is a clinical decision, not a purchase - going into the intake quiz expecting an automatic yes sets up the wrong expectation.

How Does the Zevay GLP-1 Program Work?

Based on the brand's own site content, here's the process:

  1. Complete a short online intake quiz

  2. A licensed provider affiliated with the connected medical group reviews your answers and health history

  3. The provider decides, using independent clinical judgment, whether a compounded preparation is clinically appropriate for you

  4. If prescribed, your order is routed to one of Zevay's named pharmacy partners for compounding and shipping

  5. If you're not approved, per the brand's own FAQ, you're told you'll receive a full refund

Zevay's site frames this as removing three friction points buyers commonly run into elsewhere:

  • An online path that doesn't require an in-person visit to start

  • Pricing the brand describes as free of hidden "platform fees"

  • Compounding handled by pharmacies Zevay represents as licensed in the U.S.

This article did not independently verify each pharmacy's current licensure, registration, disciplinary status, or authority to dispense in every state the program serves - these are brand claims, presented here as such. Two things worth understanding going in: completing the quiz doesn't guarantee you'll be prescribed anything, and Zevay's terms describe the service as telehealth-only and explicitly not appropriate for emergency situations - anyone experiencing a medical emergency should call 911 rather than use the platform.

Buyer Takeaway: Have your full medical history ready before you start the intake quiz - the provider's decision is only as good as the information you give them.

Buyer Takeaway: "Everything included" pricing claims are worth confirming line-by-line at checkout - taxes and shipping are mentioned separately in Zevay's own Terms of Use.

Compounded Semaglutide and Compounded Tirzepatide: What the Brand Says

Through its platform, Zevay advertises access to independent clinical evaluation for compounded semaglutide or compounded tirzepatide when a licensed provider determines treatment is clinically appropriate. Semaglutide and tirzepatide are also the names of active pharmaceutical ingredients used in certain FDA-approved medications; a compounded preparation, though, is a separately prepared, non-FDA-approved product, and shouldn't be treated as identical to, interchangeable with, or a generic version of an FDA-approved branded medication. Here's what the brand's own product pages say about each option:

  • Compounded Semaglutide - from $149/month, "up to 20% weight loss," per the dedicated product page

  • Compounded Tirzepatide - from $187/month, "up to 25% weight loss," per the dedicated product page

Worth flagging directly: Zevay's general GLP-1 landing page shows a third figure - "From $199/month" alongside the same "up to 25%" claim - that matches neither dedicated product page. This article uses the dedicated product-page figures for each medication as the more specific source, and you should confirm exact current pricing for the medication you're considering at checkout before assuming any of the three numbers applies to your plan.

On the weight-loss percentages themselves: Zevay's own site-wide disclaimer states that the weight-loss results referenced on its pages come from clinical studies of the FDA-approved versions of these medications, combined with lifestyle changes, not from studies of Zevay's compounded product specifically. Those findings relate to the specific FDA-approved medication and study protocol evaluated by researchers; they do not independently establish the safety, effectiveness, quality, dose equivalence, or expected results of the compounded preparation dispensed through Zevay's program. Individual results vary, and no compounded product carries FDA approval or an FDA-reviewed efficacy claim of its own.

Buyer Takeaway: Don't assume the lower Tirzepatide figure shown on Zevay's general landing page applies to you - the brand's own dedicated Tirzepatide page lists a higher starting price, and checkout is where you'll see the number that actually applies to your order.

Buyer Takeaway: A weight-loss percentage attached to a compounded medication is describing the FDA-approved version's clinical data, not a study of the compounded product itself - a distinction worth remembering before you set expectations.

Compare current Semaglutide and Tirzepatide pricing on Zevay's program

What the Research Says About GLP-1 and GIP Medications

Semaglutide and tirzepatide belong to a class of medications originally developed for type 2 diabetes management that has since become widely used for weight management. Semaglutide is a GLP-1 receptor agonist; tirzepatide acts on both GLP-1 and GIP receptor pathways. The FDA-approved versions of these medicines - branded as Ozempic and Wegovy for semaglutide, and Mounjaro and Zepbound for tirzepatide - have undergone FDA review for safety and effectiveness in their approved forms and doses.

Compounded versions, including the ones offered through Zevay's pharmacy partners, are not the same regulatory product. They haven't been through FDA's approval process, and the FDA does not review compounded drug quality, effectiveness, or safety before those products reach a patient. This is a general fact about compounding, not a Zevay-specific criticism - it applies to any compounded GLP-1 medication from any pharmacy. FDA states directly that compounded drugs should be used only for patients whose medical needs cannot be met by an FDA-approved drug, or where the FDA-approved drug isn't commercially available - whether that standard applies to a given patient is a clinical question for the prescribing provider to work through with you, not something this article, or Zevay's marketing, can answer in advance.

It's also worth knowing that FDA has been actively enforcing against telehealth marketing of compounded GLP-1 products through 2025 and 2026. This is category-level context, not a claim about Zevay specifically - this article found no FDA warning letter or state attorney general action naming Zevay, and none should be inferred from what follows:

  • Fall 2025: roughly 80 warning letters to telehealth companies

  • March 2026: 30 more warning letters

  • June 2026: 25 more warning letters

All three rounds targeted claims that a compounded product is equivalent to an FDA-approved drug, or that obscure which pharmacy actually compounds the medication. It's the reason this article is careful to describe compounded semaglutide and tirzepatide as containing the same active ingredient as, rather than the same as, their branded counterparts, and to name Southend Pharmacy and Boothwyn Pharmacy specifically as the compounders rather than letting "Zevay's medication" stand in for that fact.

There's also an active federal rulemaking worth understanding if you're weighing a compounded GLP-1 program in mid-2026:

  • April 30, 2026 - FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk drug substances that large-scale 503B outsourcing facilities may use to compound medications outside a declared drug shortage

  • May 1, 2026 - proposal published in the Federal Register (91 Fed. Reg. 23431), original comment deadline June 30, 2026

  • June 26, 2026 - FDA published an extension notice (91 Fed. Reg. 38719, document 2026-12937), pushing the deadline to July 30, 2026

  • As of this article's July 2026 review date, the comment period was still open and FDA had not announced a final determination

You can follow the docket directly at either link above rather than relying on this article's summary of it. The proposal targets large-batch 503B outsourcing facility compounding specifically; it doesn't, on its own, change the separate legal framework that governs 503A pharmacies compounding patient-specific prescriptions, which is the more common structure for pharmacies working directly with individual telehealth patients. It also isn't, by itself, proof of which framework Zevay's named pharmacies operate under, or a determination about any individual patient's prescription. Zevay's materials don't state whether Southend Pharmacy or Boothwyn Pharmacy operate under the 503A or 503B framework, and this article doesn't assume one or the other. If this distinction matters to you, ask Zevay's support team directly which framework its pharmacy partners use before you enroll.

Buyer Takeaway: The regulatory ground under compounded GLP-1 medications is actively shifting in 2026 - a program that looks stable today could be affected by a final FDA rule that has not yet been issued.

What's Included

Zevay advertises certain program prices using the phrase "everything included" and states that it doesn't charge separate platform fees. The materials reviewed don't provide a detailed enough breakdown to independently confirm every consultation, medication charge, supply, refill, follow-up, lab cost, shipping charge, tax, or other fee that phrase might cover. Rely on the written checkout breakdown and current subscription terms rather than assuming every possible expense is bundled in - check the current checkout flow before you enroll.

Zevay Pricing: What You'll Pay

Zevay's site currently shows three different starting prices depending on which page you land on, per the brand's own materials as reviewed in July 2026:

  • Compounded Semaglutide - from $149/month (dedicated product page)

  • Compounded Tirzepatide - from $187/month (dedicated product page)

  • General GLP-1 landing page (medication unspecified) - from $199/month

Which figure applies to you depends on which medication you're actually prescribed and what checkout shows - don't assume any single number from this article or from Zevay's own marketing pages applies to your order. Both dedicated-medication prices are billed as recurring subscriptions that renew automatically at the end of each billing cycle unless canceled.

Buyer Takeaway: Auto-renewing subscriptions are easy to forget about - mark your renewal date and the three-business-day cancellation window on a calendar the day you sign up, not the week before you want to cancel.

Cancellation works through your online account or by emailing help@zevay.com. Per Zevay's Terms of Use, cancellation requests must be received at least three business days before your next renewal date to avoid being charged for the upcoming cycle; you keep access through the end of the period you already paid for. Refunds for partially used or paused subscription periods are not provided except where required by law. The one specific refund scenario Zevay states clearly is tied to eligibility, not buyer's remorse: if you are not approved for treatment after medical review, the brand states you will receive a full refund.

View current Zevay pricing by medication

Zevay GLP-1 Reviews and Customer Testimonials

Zevay's website displays selected customer accounts discussing weight changes, confidence, energy, and lifestyle experiences. Some accounts include specific pounds-lost figures. This article did not independently verify the individuals, starting weights, treatment periods, prescribed formulations, medication doses, adherence, lifestyle interventions, adverse effects, or reported outcomes described in those accounts, and they don't establish an average, typical, or expected result from Zevay's program. No independent third-party review platform, star rating, or review count was identified in the materials reviewed for this article.

Buyer Takeaway: Brand-selected testimonials are promotional examples, not evidence of the result an average participant should expect.

The Zevay Refund and Cancellation Policy

Two different refund concepts show up in Zevay's own materials, and it is worth keeping them separate. General purchases through Zevay are described in the Terms of Use as non-refundable unless otherwise stated, with refunds, credits, or other resolutions offered only at Zevay's discretion on a case-by-case basis. Separately, and more specifically, the brand's FAQ states that if you are not approved for treatment following medical review, you will receive a full refund. This article did not find a stated refund path for someone who is approved, receives medication, and simply changes their mind - if that scenario matters to you, confirm directly with Zevay's support team before paying.

Buyer Takeaway: Zevay's stated non-approval refund applies to a specific circumstance and shouldn't be read as a general satisfaction guarantee - confirm the timing, method, and conditions of any eligibility refund before you pay.

Who May Want to Research the Zevay Program Further?

Adults researching clinician-guided telehealth weight-management options may want to compare Zevay's intake process, provider structure, compounded-medication disclosures, pricing, and subscription terms against other care pathways available to them. Whether any prescription medication, compounded or branded, is clinically appropriate has to be worked out with a licensed provider based on your own circumstances - not decided by this article or by Zevay's marketing.

A few things point toward a different kind of care instead:

  • An active medical emergency (call 911, not a telehealth platform)

  • An expectation of guaranteed approval

  • Unwillingness to consider a non-FDA-approved compounded preparation

  • An inability to reliably handle the storage or administration a compounded injectable requires

  • A need for confirmed insurance billing

  • A medical situation that genuinely calls for an in-person exam rather than a remote one

Buyer Takeaway: If a guaranteed insurance-billed option matters to you, confirm that directly with Zevay before enrolling - this article found no statement either way.

Compounded vs Brand-Name GLP-1 Medications: Category Context

Buyers weighing a program like Zevay's are usually weighing it against branded, FDA-approved options such as Ozempic, Wegovy, Mounjaro, and Zepbound, all trademarks of their respective manufacturers and not affiliated with or endorsed by Zevay. Total out-of-pocket cost for either pathway - FDA-approved branded or compounded - can vary a lot based on:

  • The specific medication and dose

  • Insurance coverage

  • Manufacturer savings programs

  • Consultation charges

  • Pharmacy fees and supplies

  • Shipping and lab work

  • Subscription terms

Compare written total costs for your specific situation rather than assuming one category is always cheaper. What the two categories don't share: an FDA-approved branded drug has gone through FDA's premarket safety and effectiveness review; a compounded preparation, including anything dispensed through Zevay's pharmacy partners, has not. Which route makes sense depends on your medical history and your own comfort with that regulatory difference - a conversation worth having directly with a licensed provider rather than settling it from marketing copy alone, Zevay's or anyone else's.

Buyer Takeaway: Cost and regulatory status are separate considerations - weigh the actual written total price and the fact that compounded preparations skip FDA premarket review, rather than assuming lower price automatically means better value.

Zevay Complaints and Consumer Concerns: What to Verify

Here's how to close out the open questions this article could not resolve from Zevay's publicly accessible materials, rather than a reason to be nervous about the brand generally. None of the items below come from a documented customer complaint record - this article did not locate or use one. These are sourcing gaps in what Zevay discloses publicly, not allegations, and every one is answerable with a direct question to Zevay's support team:

  1. Pricing conflict. Zevay's site currently shows three different starting prices: $149/month (Semaglutide product page), $187/month (Tirzepatide product page), and $199/month (general GLP-1 landing page, medication unspecified). Confirm the actual price for your specific medication at checkout before paying.

  2. The licensed medical group's exact legal entity. Zevay's site names "Telegra MD" as its affiliated independent licensed physician network. Telegra MD's own public materials describe itself, in turn, as a technology platform that facilitates telehealth for separate "Provider Groups" it doesn't itself employ, own, or supervise clinically. This article couldn't independently confirm the precise legal name of the specific licensed medical entity that will review your intake and make the prescribing decision for Zevay's program specifically.

  3. Zevay's registered business address. This article couldn't locate a publicly stated Zevay corporate street address in the materials reviewed; contact for legal matters is listed as an email address (legal@zevay.com) with certified mail directed to Zevay's "registered address," unspecified on the page reviewed.

  4. Pharmacy compounding framework. Whether Southend Pharmacy and Boothwyn Pharmacy operate under the 503A patient-specific compounding framework or the 503B outsourcing-facility framework wasn't stated in the materials reviewed, and it's relevant given the active FDA rulemaking on 503B bulk compounding of these exact medications discussed earlier in this article.

  5. Insurance and HSA/FSA eligibility. Zevay's materials reviewed for this article didn't state whether insurance, HSA, or FSA can be used toward the program cost.

  6. Shipping cost and delivery specifics. Zevay's site states that if approved, medication ships within 3 days, and its Terms of Use mention that shipping fees may be disclosed at checkout - but this article couldn't confirm the actual shipping cost, carrier, or total delivery time from a dedicated shipping policy page.

None of these depend on you doing anything complicated - a single email or chat with Zevay's support team resolves any of them before you pay.

Buyer Takeaway: None of these six items is a red flag on its own - they're gaps in what's publicly disclosed, and every one of them is answerable with a single message to Zevay's support team before you pay anything.

Check current eligibility and get today's pricing from Zevay

Is Zevay Legitimate?

Zevay presents itself, in its own materials, as a patient-management technology platform that facilitates access to independent providers and pharmacy services - not as a medical practice or pharmacy itself. Its site includes Terms of Use, a privacy framework, and named contact routes, and it discloses upfront that prescriptions are not guaranteed and that compounded medications are not FDA-approved. Zevay's site also displays a LegitScript certification seal with a link to verify approval - LegitScript is a recognized third-party certification body for online pharmacies and telehealth platforms, and Google, Meta, and Visa rely on its certifications for advertising and payment approval in this industry. This article could not independently confirm Zevay's current certification status through LegitScript's own public lookup tool, which requires an interactive form submission rather than a direct page load, so this is reported as a badge Zevay displays, not as independently verified by this article. Taken together, these disclosures give you real information to evaluate the program with. They are not an independent accreditation of Zevay, its affiliated medical group, or its pharmacy partners by this article - this article did not audit Zevay's licensing, verify provider credentials, or inspect its pharmacy partners' facilities. The verification items listed above are exactly the kind of details worth confirming directly with Zevay before you treat any of this as settled.

How Telehealth GLP-1 Programs Typically Compare to Each Other

Zevay is one of a growing number of telehealth platforms offering compounded GLP-1 medications, and most of them share a similar basic shape: an online intake, an independent licensed provider making the actual prescribing call, a compounding pharmacy fulfilling the order, and a monthly subscription price. Where programs tend to differ is in exactly the areas this article flagged for Zevay - how clearly the credentialing medical group is named, whether pricing is consistent across every page of the brand's own site, whether the compounding pharmacy's regulatory framework (503A vs. 503B) is disclosed, and how specific the refund terms are for scenarios beyond simple non-eligibility.

None of this is a claim that Zevay is better or worse than a named competitor - this article does not have independently verified data on other platforms to make that comparison responsibly. It's offered as context for what to look for, and check for, on any compounded GLP-1 telehealth site, Zevay included.

Buyer Takeaway: The questions worth asking Zevay (exact medical group entity, pharmacy compounding framework, insurance applicability) are the same questions worth asking any compounded GLP-1 telehealth brand.

Common Side Effects and Safety Considerations

Zevay's FAQ names nausea and fatigue as examples of possible side effects, but those examples aren't a complete safety profile. Prescription semaglutide and tirzepatide products carry medication-specific warnings, precautions, contraindications, interactions, and potential adverse effects beyond what's listed on a brand FAQ. FDA has specifically flagged concerns with compounded injectable GLP-1 products, including:

  • Nausea, vomiting, diarrhea, abdominal pain, and constipation

  • Excessive dosing tied to titration mistakes, some serious enough to require hospitalization

  • Concentration, measurement, labeling, and dosing considerations a mass-manufactured branded pen doesn't have in the same way

A licensed provider needs to review your full medical history, current medications, and complete medication-specific risk information with you before treatment starts - this section is a prompt to have that conversation, not a substitute for it.

Zevay's Terms of Use also note that medication form, appearance, and formulation may differ from images shown on the site, which is a normal disclosure for compounded products - unlike a mass-manufactured branded drug, a compounded medication's exact presentation, concentration, and measurement units can vary by batch and pharmacy. FDA guidance is direct on this point: don't use an injectable GLP-1 product that arrives warm or with inadequate refrigeration, since that can affect the medication's quality. Contact your dispensing pharmacy or prescribing provider for instructions instead of using the medication or trying to judge its quality yourself.

Buyer Takeaway: Nausea and fatigue are the two side effects Zevay names directly, and they're not the whole list - ask your provider about the full range of possible side effects, dosing and titration specifics, and interactions with anything else you're taking before your first dose, not after.

Get today's Zevay eligibility and pricing details

Fast Facts

  • Platform: Zevay, LLC - technology platform, not a medical practice or pharmacy

  • Affiliated medical group named by the brand: Telegra MD (independent licensed physician network, per Zevay's site)

  • Named pharmacy partners: Southend Pharmacy, Houston, TX; Boothwyn Pharmacy, Kennett Square, PA

  • Compounded Semaglutide: from $149/month, per the brand's dedicated product page

  • Compounded Tirzepatide: from $187/month, per the brand's dedicated product page (a third figure, $199/month, appears on the general landing page - confirm at checkout)

  • Weight-loss references: "up to 20%" (Semaglutide page), "up to 25%" (Tirzepatide page and general landing page) - based on studies of FDA-approved versions of these medications, brand states

  • Shipping: if approved, medication ships within 3 days, per the brand's own site

  • Displays a LegitScript certification seal/link on its site; this article could not independently confirm current certification status through LegitScript's own lookup tool

  • Non-approval refund statement: Zevay's FAQ says applicants not approved after medical review will receive a full refund; processing timing and conditions were not independently confirmed

  • General refund policy: purchases non-refundable unless otherwise stated, per Terms of Use

  • Cancellation notice window: at least 3 business days before renewal

  • Cancellation contact: help@zevay.com or online account

  • Legal contact: legal@zevay.com

  • Governing law: State of Delaware; disputes subject to binding arbitration under the Federal Arbitration Act, per Terms of Use

  • Not for emergency use, per Terms of Use - call 911 for medical emergencies

  • Also offers NAD+, HRT, and TRT programs, not covered in depth in this article

  • Compounded medications are not FDA-approved and are not FDA-reviewed for safety or effectiveness

  • Active FDA proposal: FDA has proposed not including semaglutide, tirzepatide, and liraglutide on the 503B Bulks List (91 Fed. Reg. 23431, federalregister.gov, docket 2026-08552). The comment deadline was extended to July 30, 2026 (91 Fed. Reg. 38719, document 2026-12937); no final determination had been announced as of this article's review date

Quick Answers

Zevay is a telehealth platform offering compounded semaglutide and tirzepatide for weight management, connecting users with an independent licensed medical group for review and licensed pharmacy partners for compounding. Pricing starts from $149/month for Semaglutide and $187/month for Tirzepatide, per the brand's product pages, with a full refund if you are not approved after medical review.

Compounded semaglutide is a preparation containing the same active pharmaceutical ingredient used in FDA-approved products like Ozempic and Wegovy, but the compounded version itself has not been reviewed or approved by the FDA and shouldn't be treated as identical to or interchangeable with those branded drugs. It's prescribed only if an independent licensed provider determines it's clinically appropriate for you.

Zevay's Tirzepatide pricing is listed from $187/month on the brand's dedicated product page, though Zevay's general GLP-1 landing page separately lists a $199/month starting price without naming a specific medication. This article recommends confirming the actual current price for your specific medication at checkout given that discrepancy.

You are not guaranteed a prescription simply by completing Zevay's intake quiz. A licensed provider affiliated with the brand's connected medical group reviews your information and makes an independent clinical decision; if you are not approved, the brand states you will receive a full refund.

Frequently Asked Questions

Is Zevay legit?

Zevay discloses its structure, terms, and contact information openly, and it's upfront that prescriptions aren't guaranteed and that its compounded medications aren't FDA-approved - those are good signs to look for in this category. That said, this article hasn't independently accredited Zevay, its medical group, or its pharmacy partners. Confirm the open items above (exact medical group entity, pharmacy compounding framework, insurance) directly with Zevay before treating the program as fully vetted.

What is Zevay?

Zevay, LLC is a telehealth patient management platform that connects users with an independent licensed physician network the brand identifies as Telegra MD, and with licensed pharmacy partners, for compounded GLP-1 weight-management medication. Zevay itself does not practice medicine or pharmacy and states this directly in its Terms of Use.

What medications does Zevay offer?

Compounded Semaglutide and Compounded Tirzepatide, both GLP-1-class medications used for weight management. Zevay's site also lists NAD+, HRT, and TRT programs, which are outside the scope of this article.

How much does Zevay cost?

Per the brand's product pages reviewed for this article, Compounded Semaglutide starts from $149/month and Compounded Tirzepatide starts from $187/month. Zevay's general GLP-1 landing page, which doesn't specify a medication, separately lists a $199/month starting price; confirm your actual price for your specific medication at checkout.

Is Zevay's medication FDA-approved?

No. Compounded preparations discussed through Zevay's program are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Semaglutide and tirzepatide are also active pharmaceutical ingredients used in certain FDA-approved medications, but a compounded preparation is a separate, non-FDA-approved product and isn't the same regulatory product as those branded drugs.

Is Zevay a medical provider?

No. Zevay describes itself as a technology platform, not a medical practice. Clinical evaluations and prescribing decisions are made by an independent licensed provider affiliated with the medical group Zevay identifies as Telegra MD.

Is Zevay a pharmacy?

No. Zevay names two pharmacy partners - Southend Pharmacy and Boothwyn Pharmacy - that prepare and dispense compounded medication when a provider prescribes it. Zevay itself does not compound or dispense.

Will I definitely be prescribed medication if I sign up?

No. Per Zevay's own FAQ and Terms of Use, every prescribing decision is made independently by a licensed provider after reviewing your health information, and a prescription is not guaranteed. If you are not approved, the brand states you will receive a full refund.

What happens if I am not approved for treatment?

The brand's FAQ states you will receive a full refund if you are not approved for treatment following medical review.

Can I get a refund after I've started treatment?

Zevay's Terms of Use state that purchases are non-refundable unless otherwise stated, with refunds offered at the brand's discretion on a case-by-case basis. This article did not locate a stated refund path specifically for buyer's-remorse cancellations after medication has shipped; confirm directly with Zevay support if this matters to your decision.

How do I cancel a Zevay subscription?

Through your online account or by emailing help@zevay.com. Per the Terms of Use, cancellation requests must be received at least three business days before your next renewal date to avoid being charged for the upcoming billing cycle.

Review Zevay's current program terms and pricing

Who actually prescribes the medication - Zevay or someone else?

Not Zevay. Prescribing decisions are made by an independent licensed provider affiliated with the medical group the brand names as Telegra MD. This article could not independently confirm the exact legal entity name of the specific credentialing medical group behind Zevay's program, since Telegra MD's own materials describe itself as a facilitating technology platform working through separate, unnamed "Provider Groups."

Which pharmacy fills Zevay prescriptions?

Zevay's Terms of Use name two pharmacy partners: Southend Pharmacy in Houston, Texas, and Boothwyn Pharmacy in Kennett Square, Pennsylvania.

Are Zevay's pharmacies 503A or 503B compounding pharmacies?

This article could not confirm that classification from the materials reviewed. It's a relevant question given the active FDA rulemaking discussed above (91 Fed. Reg. 23431, with a comment deadline extended to July 30, 2026 by 91 Fed. Reg. 38719), which would, if finalized, affect 503B bulk compounding of semaglutide and tirzepatide specifically - though the proposal itself isn't proof of which framework Zevay's named pharmacies actually use. Ask Zevay's support team directly if this distinction matters to your decision.

Does Zevay automatically renew?

Yes. Per Zevay's Terms of Use, subscriptions renew automatically at the end of each billing cycle unless canceled at least three business days before the renewal date.

Why might a provider prescribe a compounded medication instead of a branded one?

FDA guidance states that compounded drugs should be used only when a patient's medical need can't be met by an FDA-approved drug, or when the FDA-approved version isn't commercially available. Whether that applies to you is a clinical determination your provider makes, not something Zevay's marketing or this article can decide in advance.

What happens if my medication arrives warm or without proper refrigeration?

FDA guidance says not to use an injectable GLP-1 product that arrives warm or with inadequate refrigeration, since that can affect quality. Contact your dispensing pharmacy or provider for instructions rather than using it or trying to judge its condition yourself.

Does insurance cover Zevay's program?

This article could not confirm whether insurance, HSA, or FSA funds can be used toward Zevay's program cost. Insurance coverage, if any, depends on your specific plan and is not confirmed by this article.

Is Zevay the same as Ozempic, Wegovy, Mounjaro, or Zepbound?

No. Those are FDA-approved brand-name medications trademarked by Novo Nordisk and Eli Lilly and Company respectively. Zevay states clearly in its own disclosures that it's not affiliated with, endorsed by, or a supplier of those specific branded products. The compounded preparations discussed through Zevay's program contain the same active pharmaceutical ingredients but are a separate, non-FDA-approved product category and shouldn't be treated as generic or interchangeable versions of the branded drugs.

How much weight can I expect to lose on Zevay's program?

Zevay references "up to 20%" weight loss for its Semaglutide program and "up to 25%" for its Tirzepatide program. The brand states these figures come from clinical studies of the FDA-approved versions of these medications combined with lifestyle changes, not from studies of Zevay's specific compounded product. Individual results vary.

Is Zevay appropriate for a medical emergency?

No. Zevay's Terms of Use state the service is not intended for emergency or urgent medical situations. Call 911 or seek in-person emergency care if you believe you are experiencing a medical emergency.

Where is Zevay based?

This article could not locate a publicly stated corporate street address for Zevay, LLC in the materials reviewed. The brand's Terms of Use are governed by Delaware law, with arbitration seated in New Castle County, Delaware. Legal correspondence is directed to legal@zevay.com.

Buyer Verification Checklist

  1. Confirm the exact monthly price for the specific medication (Semaglutide or Tirzepatide) at checkout, given the pricing conflict identified in this article.

  2. Ask Zevay's support team to confirm the exact legal name of the medical group entity that will review your case.

  3. Ask whether your assigned pharmacy partner is a 503A or 503B compounding pharmacy.

  4. Confirm whether insurance, HSA, or FSA funds can be applied to your program cost.

  5. Confirm current shipping cost and delivery timeline before paying.

  6. Review the cancellation window (3 business days before renewal) and set a reminder if you plan to cancel.

  7. Confirm what happens to a partially used billing period if you cancel mid-cycle.

  8. Read the full eligibility quiz disclosure - completing it does not guarantee a prescription.

  9. Confirm with your own physician whether a compounded GLP-1 medication is appropriate given your full medical history.

  10. Save Zevay's support contact (help@zevay.com) and legal contact (legal@zevay.com) before you need them.

Start Zevay's eligibility quiz and see today's program pricing

The Bottom Line

Zevay is a telehealth platform advertising access to independent clinical evaluation for compounded semaglutide and compounded tirzepatide, with prescriptions issued only when an independent licensed provider determines treatment is clinically appropriate. Its materials identify pharmacy partners and display starting monthly prices for the two program pathways. The three-entity structure - platform, medical group, pharmacy - is disclosed, and the brand is direct about the fact that a prescription is not guaranteed and that its compounded medications are not FDA-approved.

What is not fully resolved from Zevay's public materials: which exact legal entity credentials the reviewing providers beneath "Telegra MD," which compounding framework its pharmacy partners operate under, whether insurance applies, current LegitScript certification status, and a live pricing conflict - three different starting prices ($149, $187, and $199 per month) appear across Zevay's own pages depending on which one you land on. None of those are dealbreakers on their own, but they are exactly the kind of details worth nailing down with Zevay's support team directly before you commit to a subscription and a medication decision.

Zevay Contact Information

  • Support and cancellation: help@zevay.com or your online account

  • Legal correspondence: legal@zevay.com, or certified mail to Zevay's registered address (not publicly stated in materials reviewed for this article)

  • Southend Pharmacy: 415 Westheimer Rd. Ste 103, Houston, TX 77006

  • Boothwyn Pharmacy: 221 Gale Lane, Kennett Square, PA 19348

  • Official site: zevay.com

Disclosure and Compliance Information

Material Limitations. This article is based on Zevay's own website content (homepage, Semaglutide product page, Tirzepatide product page, Contact Us page, About Us page, Terms of Use), independent research into Telegra MD's public materials, current FDA guidance on unapproved compounded GLP-1 drugs and FDA's telehealth warning-letter enforcement pattern (fda.gov), and two Federal Register notices: 91 Fed. Reg. 23431 (federalregister.gov/documents/2026/05/01/2026-08552) and the June 26, 2026 comment-period extension at 91 Fed. Reg. 38719 (federalregister.gov/documents/2026/06/26/2026-12937), all reviewed in July 2026. No independent testing of Zevay's program, medications, or providers was conducted. Brand claims, including weight-loss percentages, pricing, testimonial outcomes, and the displayed LegitScript seal, are not independently verified by this article and are attributed to the brand throughout. Title phrases in this article reflect standard program-overview terminology, not brand-originated marketing language requiring separate scaffolding. The following facts could not be confirmed from materials reviewed and were omitted or flagged rather than assumed: Zevay's corporate street address (Contact Us lists only an email address); the specific legal entity name of the medical group crediting the providers who review Zevay intakes (Zevay's site names "Telegra MD," while Telegra MD's own materials describe itself as a facilitating platform working through separate, unnamed Provider Groups - both statements are reported here as stated by their respective sources, with the underlying credentialing entity unconfirmed); whether Southend Pharmacy or Boothwyn Pharmacy operate under the 503A or 503B compounding framework; insurance, HSA, and FSA applicability; current LegitScript certification status (the lookup tool requires interactive form submission rather than a direct page load); and specific shipping cost or total delivery time (the brand states medication ships within 3 days if approved, which this article reads as a processing/dispatch figure rather than a confirmed arrival date). The pricing conflict - three different starting prices ($149, $187, and $199 per month) across three different pages of Zevay's own site - is documented above rather than resolved by this article; the dedicated product-page figures ($149 Semaglutide, $187 Tirzepatide) are used as the more specific source, and readers are directed to confirm current pricing at checkout.

Third-Party Feedback Platforms. The accuracy of third-party review platforms referenced or implied in connection with this brand is not endorsed by this article; evaluate any such reviews critically and independently.

Forward-Looking Statements. This article reflects information available in July 2026. Zevay's pricing, program structure, medication offerings, and policies may change after publication. Rely on Zevay's official site for current information before making any purchase or treatment decision.

Marketing Language Notice. Attribution language throughout this article identifies statements as brand claims. References to weight-loss outcomes, pricing, and program benefits reflect Zevay's own marketing language and are not independent rankings, lab-verified claims, or guarantees of individual results.

Zevay's compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality before reaching patients. This article does not diagnose, treat, cure, or prevent any disease or condition, and nothing in this article constitutes medical advice. Consult a qualified healthcare provider with questions about whether a GLP-1 or GIP medication, compounded or branded, is appropriate for you.

Geographic and jurisdictional note: Zevay's Terms of Use state the service is governed by Delaware law, with disputes subject to binding arbitration under the Federal Arbitration Act in New Castle County, Delaware, except where prohibited by applicable law. Availability of services may vary by state.

Trademark Acknowledgment: Zevay is the trade name used by Zevay, LLC in the materials reviewed for this article; no representation is made regarding federal or state trademark registration status. Saxenda®, Victoza®, Wegovy®, and Ozempic® are trademarks of Novo Nordisk. Mounjaro and Zepbound are trademarks of Eli Lilly and Company. Zevay is not affiliated with, endorsed by, or a supplier of any of these branded medications, per the brand's own disclosure. Telegra MD is referenced as identified on Zevay's own site and is not owned by or affiliated with the publisher of this article.

SOURCE: Zevay

Source: Zevay

Zevay